Počet záznamů: 1
Lenalidomide treatment in lower risk myelodysplastic syndromes-The experience of a Czech hematology center. (Positive effect of erythropoietin +/- prednisone addition to lenalidomide in refractory or relapsed patients)
- 1.JONASOVA, A., NEUWIRTOVÁ, R., POLACKOVA, H., ŠIŠKOVÁ, M., STOPKA, T., CMUNT, E., BELICKOVA, M., MOUDRÁ, Alena, MINAŘÍK, L., FUCHS, O., MICHALOVÁ, K., ZEMANOVÁ, Z. Lenalidomide treatment in lower risk myelodysplastic syndromes-The experience of a Czech hematology center. (Positive effect of erythropoietin +/- prednisone addition to lenalidomide in refractory or relapsed patients). Leukemia Research. 2018, 69(June), 12-17. ISSN 0145-2126. E-ISSN 1873-5835. Dostupné z: doi: 10.1016/j.leukres.2018.03.015.
Počet záznamů: 1